Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Hagan

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Psychopharmacology|January 1, 1993
Interactions between 5-HT3 receptors and cerebral dopamine function: implications for the treatment of schizophrenia and psychoactive substance abuseR M Hagan, G J Kilpatrick, M B Tyers
European Journal of Pharmacology|November 11, 1998
Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in ratsE Southam, D Kirkby, G A Higgins, et al.
European Journal of Pharmacology|March 17, 1992
Neurokinin agonists differentially affect A9 and A10 dopamine cells in the ratP Overton, P J Elliott, R M Hagan, et al.
Neuroscience|January 1, 1992
Ontogeny and characterization of [125I]Bolton Hunter-eledoisin binding sites in rat spinal cord by quantitative autoradiographyI J Beresford, S J Ireland, J Stables, et al.
Neuroreport|October 2, 1995
Modulation of the rat suprachiasmatic circadian clock by melatonin in vitroS J Starkey, M P Walker, I J Beresford, et al.
British Journal of Pharmacology|October 1, 1991
Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345I J Beresford, P J Birch, R M Hagan, et al.
British Journal of Pharmacology|February 1, 1990
Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the ratR M Hagan, B J Jones, C C Jordan, et al.
International Journal of Peptide and Protein Research|December 1, 1993
Synthesis of a potent antagonist of substance P by replacing the CH2SCH3 and the alpha-carboxamide groups of the methionine at [Orn6]-SP6-11 by benzyl ester groupsK Karagiannis, G Stavropoulos, C Poulos, et al.
European Journal of Pharmacology|December 27, 1995
Temperature and agonist dependency of tachykinin NK1 receptor antagonist potencies in rat isolated superior cervical ganglionA B Hawcock, I J Beresford, F H Marshall, et al.
Neuropeptides|June 1, 1991
Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonistsP J Elliott, G S Mason, M Stephens-Smith, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Psychopharmacology|January 1, 1993
Interactions between 5-HT3 receptors and cerebral dopamine function: implications for the treatment of schizophrenia and psychoactive substance abuseR M Hagan, G J Kilpatrick, M B Tyers
European Journal of Pharmacology|November 11, 1998
Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in ratsE Southam, D Kirkby, G A Higgins, et al.
European Journal of Pharmacology|March 17, 1992
Neurokinin agonists differentially affect A9 and A10 dopamine cells in the ratP Overton, P J Elliott, R M Hagan, et al.
Neuroscience|January 1, 1992
Ontogeny and characterization of [125I]Bolton Hunter-eledoisin binding sites in rat spinal cord by quantitative autoradiographyI J Beresford, S J Ireland, J Stables, et al.
Neuroreport|October 2, 1995
Modulation of the rat suprachiasmatic circadian clock by melatonin in vitroS J Starkey, M P Walker, I J Beresford, et al.
British Journal of Pharmacology|October 1, 1991
Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345I J Beresford, P J Birch, R M Hagan, et al.
British Journal of Pharmacology|February 1, 1990
Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the ratR M Hagan, B J Jones, C C Jordan, et al.
International Journal of Peptide and Protein Research|December 1, 1993
Synthesis of a potent antagonist of substance P by replacing the CH2SCH3 and the alpha-carboxamide groups of the methionine at [Orn6]-SP6-11 by benzyl ester groupsK Karagiannis, G Stavropoulos, C Poulos, et al.
European Journal of Pharmacology|December 27, 1995
Temperature and agonist dependency of tachykinin NK1 receptor antagonist potencies in rat isolated superior cervical ganglionA B Hawcock, I J Beresford, F H Marshall, et al.
Neuropeptides|June 1, 1991
Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonistsP J Elliott, G S Mason, M Stephens-Smith, et al.
Pageof 5